The latest prostate cancer news
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)…
Breast Cancer Now and Prostate Cancer Research have joined forces to fund six groundbreaking new…
New observational evidence from a large US cohort suggests that, for men with metastatic castration-resistant…
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8…
A new Moffitt Cancer Centre study suggests a widely used genomic test can more accurately identify which…
The Alliance for Clinical Trials in Oncology has launched a randomised phase III clinical trial…
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could…
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate,…
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment,…
On December 12, 2025, the Food and Drug Administration approved niraparib and abiraterone acetate with prednisone…